Health Services Research
Latest posts by Health Services Research (see all)
- Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without… - Oct. 01, 2015
- The Quality of Surgical and Pneumonia Care in Minority-Serving and Racially Integrated… - Sep. 29, 2015
- The Effects of Job Insecurity on Health Care Utilization: Findings from a Panel of U.S. Workers - Sep. 29, 2015
- The Influence of Respondent Characteristics on the Validity of Self-Reported Survey Responses - Sep. 15, 2015
Background Assessing the real-world comparative effectiveness of common interventions is challenged by unmeasured confounding. Objective To determine whether the mortality benefit shown for drug-eluting stents (DES) over bare metal stents (BMS) in observational studies persists after controls for/tests for confounding. Data Sources/Study Setting Retrospective observational study involving 38,019 patients, 65 years or older admitted for an index percutaneous coronary intervention receiving DES or BMS in Pennsylvania in 2004–2005 followed up for death through 3 years. Study Design Analysis was at the patient level.